Quantum dot fluorescence-based platform for in vitro diagnostic applications. Supports development of various immunological assays with enhanced optical properties and batch consistency.
Manufactured by
Shenzhen Kingfocus Biomedical Engineering Co., Ltd.
China
As pioneers of the world's first quantum dots POCT platform, we have led the industry for over 10 years since 2012, driven by relentless innovation and a commitment to excellence. We are dedicated to providing high-accuracy POCT product solutions, powered by our proprietary quantum dots platform, immunoassay technology, and comprehensive in vitro diagnostic expertise.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
ZIODIA Co., Ltd.
South Korea · 2 relevant products
Anhui Huibang Biological Engineering Co., Ltd.
China · 1 relevant product
Beijing Zhongjian Antai Diagnostic Co., Ltd.
China · 1 relevant product
16 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →2 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 32 closest product alternatives
ZIODIA Co., Ltd. · South Korea
A platform for immune diagnosis devices based on Quantum Dot fluorescence measurement mode technology. It includes Quantum Dot labeled detection kits for enhanced sensitivity, precise analysis, and multiplex analysis capabilities. The platform offers both Gold Type and Quantum Dot Type kits with sensitivity down to ng/ml levels and 500-1,000 fold higher accuracy compared to gold standard detection methods.
Anhui Huibang Biological Engineering Co., Ltd. · China
Quantum dot-based detection platform for in vitro diagnostic testing of urine biomarkers. Enables multi-channel composite analysis for early detection of diabetic nephropathy and premature rupture of membranes through dry-reagent immunoassay technology. Supports both clinical laboratory quantification and point-of-care patient self-testing with mobile device image capture and server-based result analysis.
Beijing Zhongjian Antai Diagnostic Co., Ltd. · China
Fluorescence quantitative immunoassay platform for in vitro diagnostic testing of infectious diseases, respiratory pathogens, and gastrointestinal markers. The system enables quantitative analysis using fluorescence immunoassay technology with Class II medical device certification across multiple regulatory markets. Supports high-throughput diagnostic workflows in clinical laboratories and reference testing facilities.
29 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products